Synthesis and Antimycobacterial Activity of 2-(Phenylthio) Benzoylarylhydrazone Derivatives

Overview

Journal Iran J Pharm Res

Publisher Brieflands

Specialty Pharmacology

Date 2013 Nov 20

PMID 24250407

Citations 3

Authors

Ali Almasirad

Somayeh Samiee-Sadr

Abbas Shafiee

Affiliations

Soon will be listed here.

Abstract

A series of new 2-(phenylthio) benzoylarylhydrazones were synthesized by acid-catalyzed condensation of hydrazide 3 with corresponding aldehydes. The chemical structures of the compounds were elucidated by FT-IR, (1)H-NMR and Mass spectra. All newly synthesized compounds were evaluated for their antimycobacterial activities against Mycobacterium tuberculosis H37Rv using the microplatealamar blue assay (MABA). Compounds 4f (5-Nitro-2-furyl analogue) and 4g (5-Nitro-2-thienyl analogue) showed antimycobacterial activity with IC90, 7.57 and 2.96 μg/mL, respectively.

Citing Articles

A novel hydrazide compound exerts anti-metastatic effect against breast cancer.

Dehghani S, Kooshafar Z, Almasirad A, Tahmasvand R, Moayer F, Muhammadnejad A Biol Res. 2019; 52(1):40.

PMID: 31387647 PMC: 6683344. DOI: 10.1186/s40659-019-0247-2.

Synthesis and evaluation of new fluorinated anti-tubercular compounds.

Esfahanizadeh M, Omidi K, Kauffman J, Gudarzi A, Shahraki Zahedani S, Amidi S Iran J Pharm Res. 2014; 13(1):115-26.

PMID: 24734062 PMC: 3985232.

Synthesis and analgesic activity of novel hydrazide and hydrazine derivatives.

Koopaei M, Assarzadeh M, Almasirad A, Ghasemi-Niri S, Amini M, Kebriaeezadeh A Iran J Pharm Res. 2014; 12(4):721-7.

PMID: 24523751 PMC: 3920700.

References

Letafat B, Emami S, Aliabadi A, Mohammadhosseini N, Moshafi M, Asadipour A . Synthesis and in-vitro antibacterial activity of 5-substituted 1-methyl-4-nitro-1H-imidazoles. Arch Pharm (Weinheim). 2008; 341(8):497-501. DOI: 10.1002/ardp.200800022. View

Chiang C, Schaaf H . Management of drug-resistant tuberculosis. Int J Tuberc Lung Dis. 2010; 14(6):672-82. View

Levy S . Antibiotic resistance-the problem intensifies. Adv Drug Deliv Rev. 2005; 57(10):1446-50. DOI: 10.1016/j.addr.2005.04.001. View

Herzigova P, Klimesova V, Palat K, Kaustova J, Dahse H, Mollmann U . Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents. Arch Pharm (Weinheim). 2009; 342(7):394-404. DOI: 10.1002/ardp.200800227. View

Imramovsky A, Vinsova J, Ferriz J, Dolezal R, Jampilek J, Kaustova J . New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains. Bioorg Med Chem. 2009; 17(10):3572-9. DOI: 10.1016/j.bmc.2009.04.008. View

Franzblau S, Witzig R, McLAUGHLIN J, Torres P, Madico G, Hernandez A . Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol. 1998; 36(2):362-6. PMC: 104543. DOI: 10.1128/JCM.36.2.362-366.1998. View

Kaplancikli Z, Turan-Zitouni G, Ozdemir A, Teulade J . Synthesis and antituberculosis activity of new hydrazide derivatives. Arch Pharm (Weinheim). 2008; 341(11):721-4. DOI: 10.1002/ardp.200800048. View

Almasirad A, Hosseini R, Jalalizadeh H, Rahimi-Moghaddam Z, Abaeian N, Janafrooz M . Synthesis and analgesic activity of 2-phenoxybenzoic acid and N-phenylanthranilic acid hydrazides. Biol Pharm Bull. 2006; 29(6):1180-5. DOI: 10.1248/bpb.29.1180. View

Bhowruth V, Dover L, Besra G . Tuberculosis chemotherapy: recent developments and future perspectives. Prog Med Chem. 2007; 45:169-203. DOI: 10.1016/S0079-6468(06)45504-1. View

10.

Foroumadi A, Soltani F, Jabini R, Moshafi M, Mohammadian Rasnani F . Antituberculosis agents X. Synthesis and evaluation of in vitro antituberculosis activity of 2-(5-nitro-2-furyl)- and 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,3,4-thiadiazole derivatives. Arch Pharm Res. 2004; 27(5):502-6. DOI: 10.1007/BF02980122. View

11.

Trivedi A, Dodiya D, Surani J, Jarsania S, Mathukiya H, Ravat N . Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines. Arch Pharm (Weinheim). 2008; 341(7):435-9. DOI: 10.1002/ardp.200800027. View

12.

Sriram D, Yogeeswari P, Madhu K . Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones. Bioorg Med Chem Lett. 2005; 15(20):4502-5. DOI: 10.1016/j.bmcl.2005.07.011. View

13.

Foroumadi A, Kiani Z, Soltani F . Antituberculosis agents VIII. Synthesis and in vitro antimycobacterial activity of alkyl alpha-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-ylthio]acetates. Farmaco. 2003; 58(11):1073-6. DOI: 10.1016/s0014-827x(03)00158-7. View

14.

Poole K . Multidrug resistance in Gram-negative bacteria. Curr Opin Microbiol. 2001; 4(5):500-8. DOI: 10.1016/s1369-5274(00)00242-3. View

15.

Foroumadi A, Kargar Z, Sakhteman A, Sharifzadeh Z, Feyzmohammadi R, Kazemi M . Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl)-1,3,4-thiadiazol-2-ylthio]propionates. Bioorg Med Chem Lett. 2005; 16(5):1164-7. DOI: 10.1016/j.bmcl.2005.11.087. View

16.

Kaufmann S . Protection against tuberculosis: cytokines, T cells, and macrophages. Ann Rheum Dis. 2002; 61 Suppl 2:ii54-8. PMC: 1766701. DOI: 10.1136/ard.61.suppl_2.ii54. View

17.

Almasirad A, Tajik M, Bakhtiari D, Shafiee A, Abdollahi M, Zamani M . Synthesis and analgesic activity of N-Arylhydrazone derivatives of mefenamic acid. J Pharm Pharm Sci. 2006; 8(3):419-25. View